{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:51:24Z","timestamp":1792929084069,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,24]]},"DOI":"10.7759\/cureus.97640","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:26:54Z","timestamp":1763987214000},"source":"Crossref","is-referenced-by-count":6,"title":["Adverse Drug Reactions and Drug Interactions in Multimorbid Patients: A Review of Current Evidence"],"prefix":"10.7759","author":[{"given":"Harsh","family":"S","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Venuturumilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmuga Priya","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Harsha Vardhan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikramaditya","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairya Ajaykumar","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","volume":"12","author":"Zazzara MB","year":"2021","unstructured":"Zazzara MB, Palmer K, Vetrano DL, Carf\u00ec A, Onder G. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med. 2021, 12:463-73. 10.1007\/s41999-021-00481-9","journal-title":"Eur Geriatr Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055551","article-title":"Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions","volume":"12","author":"Osanlou R","year":"2022","unstructured":"Osanlou R, Walker L, Hughes DA, Burnside G, Pirmohamed M. Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. BMJ Open. 2022, 12:e055551. 10.1136\/bmjopen-2021-055551","journal-title":"BMJ Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.19035","article-title":"Clinical impact of medication review and deprescribing in older inpatients: a systematic review and meta-analysis","volume":"72","author":"Carollo M","year":"2024","unstructured":"Carollo M, Crisafulli S, Vitturi G, et al.. Clinical impact of medication review and deprescribing in older inpatients: a systematic review and meta-analysis. J Am Geriatr Soc. 2024, 72:3219-38. 10.1111\/jgs.19035","journal-title":"J Am Geriatr Soc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2023.04.008","article-title":"Adverse drug event prevention and detection in older emergency department patients","volume":"39","author":"Koehl JL","year":"2023","unstructured":"Koehl JL. Adverse drug event prevention and detection in older emergency department patients. Clin Geriatr Med. 2023, 39:635-45. 10.1016\/j.cger.2023.04.008","journal-title":"Clin Geriatr Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-024-01025-7","article-title":"A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial","volume":"15","author":"Simal I","year":"2024","unstructured":"Simal I, Somers A, Amrouch C, et al.. A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial. Eur Geriatr Med. 2024, 15:1357-67. 10.1007\/s41999-024-01025-7","journal-title":"Eur Geriatr Med"},{"key":"ref6","article-title":"[Social prescribing to reduce polypharmacy in patients with COPD in general practice]","volume":"185","author":"Andelius DK","year":"2023","unstructured":"Andelius DK, Jessen NH, L\u00f8kke A, Nielsen R\u00d8, Jacobsen JS. [Social prescribing to reduce polypharmacy in patients with COPD in general practice]. Ugeskr Laeger. 2023, 185:V05230343.","journal-title":"Ugeskr Laeger"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S338601","article-title":"Drug-drug-gene interactions in cardiovascular medicine","volume":"15","author":"Asiimwe IG","year":"2022","unstructured":"Asiimwe IG, Pirmohamed M. Drug-drug-gene interactions in cardiovascular medicine. Pharmgenomics Pers Med. 2022, 15:879-911. 10.2147\/PGPM.S338601","journal-title":"Pharmgenomics Pers Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01300-w","article-title":"Adverse drug reactions and drug-related problems with supportive care medications among the oncological population","volume":"15","author":"Tajani BB","year":"2024","unstructured":"Tajani BB, Maheswari E, Maka VV, Nair AS. Adverse drug reactions and drug-related problems with supportive care medications among the oncological population. Discov Oncol. 2024, 15:416. 10.1007\/s12672-024-01300-w","journal-title":"Discov Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2022.000050","article-title":"Increasing trend in hospitalisation due to adverse drug reactions: can we stem the tide?","volume":"61","author":"Walker LE","year":"2023","unstructured":"Walker LE, Pirmohamed M. Increasing trend in hospitalisation due to adverse drug reactions: can we stem the tide?. Drug Ther Bull. 2023, 61:87-91. 10.1136\/dtb.2022.000050","journal-title":"Drug Ther Bull"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ph14101056","article-title":"Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (the IDrug randomized controlled trial)-never change a running system?","volume":"14","author":"Just KS","year":"2021","unstructured":"Just KS, Scholl C, Boehme M, et al.. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (the IDrug randomized controlled trial)-never change a running system?. Pharmaceuticals (Basel). 2021, 14:1056. 10.3390\/ph14101056","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afab120","article-title":"Corrigendum to: prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial","volume":"50","author":"O'Mahony D","year":"2021","unstructured":"O'Mahony D, Gudmundsson A, Soiza RL, et al.. Corrigendum to: prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age Ageing. 2021, 50:e10-1. 10.1093\/ageing\/afab120","journal-title":"Age Ageing"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2024.105151","article-title":"The association of dementia with incident adverse drug reactions in hospitalized older adults","volume":"25","author":"Rodriguez-Espeso EA","year":"2024","unstructured":"Rodriguez-Espeso EA, Verdejo-Bravo C, Cherubini A, et al.. The association of dementia with incident adverse drug reactions in hospitalized older adults. J Am Med Dir Assoc. 2024, 25:105151. 10.1016\/j.jamda.2024.105151","journal-title":"J Am Med Dir Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2024.0388","article-title":"Polypharmacy in older patients","volume":"85","author":"Woodford HJ","year":"2024","unstructured":"Woodford HJ. Polypharmacy in older patients. Br J Hosp Med (Lond). 2024, 85:1-12. 10.12968\/hmed.2024.0388","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2174\/1574886318666230816090606","article-title":"Incidence and severity of adverse drug reactions in medical intensive care unit","volume":"19","author":"Shaikh S","year":"2024","unstructured":"Shaikh S, Raut A, Jambhale P, Iyer S, Shah J. Incidence and severity of adverse drug reactions in medical intensive care unit. Curr Drug Saf. 2024, 19:332-41. 10.2174\/1574886318666230816090606","journal-title":"Curr Drug Saf"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/PTS.0000000000000552","article-title":"Validating a trigger tool for detecting adverse drug events in elderly patients with multimorbidity (TRIGGER-CHRON)","volume":"17","author":"Toscano Guzm\u00e1n MD","year":"2021","unstructured":"Toscano Guzm\u00e1n MD, Banqueri MG, Otero MJ, Fidalgo SS, Noguera IF, Guerrero MC. Validating a trigger tool for detecting adverse drug events in elderly patients with multimorbidity (TRIGGER-CHRON). J Patient Saf. 2021, 17:e976-82. 10.1097\/PTS.0000000000000552","journal-title":"J Patient Saf"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101381","article-title":"Individual pharmacotherapy management (IPM)-IV: optimized usage of approved antimicrobials addressing under-recognized adverse drug reactions and drug-drug interactions in polypharmacy","volume":"11","author":"Wolf U","year":"2022","unstructured":"Wolf U, Baust H, Neef R, Steinke T. Individual pharmacotherapy management (IPM)-IV: optimized usage of approved antimicrobials addressing under-recognized adverse drug reactions and drug-drug interactions in polypharmacy. Antibiotics (Basel). 2022, 11:1381. 10.3390\/antibiotics11101381","journal-title":"Antibiotics (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/a-1226-4647","article-title":"[Current challenges in pharmacotherapy]","volume":"56","author":"Just KS","year":"2021","unstructured":"Just KS. [Current challenges in pharmacotherapy]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2021, 56:652-65. 10.1055\/a-1226-4647","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.14616","article-title":"Effect of drugs on nutritional status and drug-nutrition interactions in older patients","volume":"23","author":"Kuzuya M","year":"2023","unstructured":"Kuzuya M. Effect of drugs on nutritional status and drug-nutrition interactions in older patients. Geriatr Gerontol Int. 2023, 23:465-77. 10.1111\/ggi.14616","journal-title":"Geriatr Gerontol Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/PTS.0000000000000389","article-title":"Development of a trigger tool to identify adverse drug events in elderly patients with multimorbidity","volume":"17","author":"Toscano Guzm\u00e1n MD","year":"2021","unstructured":"Toscano Guzm\u00e1n MD, Galv\u00e1n Banqueri M, Otero MJ, Alfaro Lara ER, Casajus Lagranja P, Santos Ramos B. Development of a trigger tool to identify adverse drug events in elderly patients with multimorbidity. J Patient Saf. 2021, 17:e475-82. 10.1097\/PTS.0000000000000389","journal-title":"J Patient Saf"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/arm91010008","article-title":"Evaluation of drug interactions in hospitalized patients with respiratory disorders in Greece","volume":"91","author":"Spanakis M","year":"2023","unstructured":"Spanakis M, Ioannou P, Tzalis S, et al.. Evaluation of drug interactions in hospitalized patients with respiratory disorders in Greece. Adv Respir Med. 2023, 91:74-92. 10.3390\/arm91010008","journal-title":"Adv Respir Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-023-00903-w","article-title":"Diabetes mellitus increases risk of adverse drug reactions and death in hospitalised older people: the SENATOR trial","volume":"15","author":"Chinmayee A","year":"2024","unstructured":"Chinmayee A, Subbarayan S, Myint PK, et al.. Diabetes mellitus increases risk of adverse drug reactions and death in hospitalised older people: the SENATOR trial. Eur Geriatr Med. 2024, 15:189-99. 10.1007\/s41999-023-00903-w","journal-title":"Eur Geriatr Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00391-021-01907-6","article-title":"Antirheumatic drugs in older adults and polypharmacy issues","volume":"55","author":"Coskun Benlidayi I","year":"2022","unstructured":"Coskun Benlidayi I, Gokce Kutsal Y. Antirheumatic drugs in older adults and polypharmacy issues. Z Gerontol Geriatr. 2022, 55:507-12. 10.1007\/s00391-021-01907-6","journal-title":"Z Gerontol Geriatr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2021.05.006","article-title":"Polypharmacy among COVID-19 patients: a systematic review","volume":"61","author":"Iloanusi S","year":"2021","unstructured":"Iloanusi S, Mgbere O, Essien EJ. Polypharmacy among COVID-19 patients: a systematic review. J Am Pharm Assoc (2003). 2021, 61:e14-25. 10.1016\/j.japh.2021.05.006","journal-title":"J Am Pharm Assoc (2003)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/eurjcn\/zvac113","article-title":"Nurses as adverse drug reaction reporting advocates","volume":"22","author":"Schj\u00f8tt J","year":"2023","unstructured":"Schj\u00f8tt J, Pettersen TR, Andreassen LM, Bj\u00e5nes TK. Nurses as adverse drug reaction reporting advocates. Eur J Cardiovasc Nurs. 2023, 22:765-8. 10.1093\/eurjcn\/zvac113","journal-title":"Eur J Cardiovasc Nurs"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/10781552231207839","article-title":"Rationalizing prescription via deprescribing in oncology practice","volume":"29","author":"Raju B","year":"2023","unstructured":"Raju B, Chaudhary RK, L A, Babu A, Sandeep A, Mateti UV. Rationalizing prescription via deprescribing in oncology practice. J Oncol Pharm Pract. 2023, 29:2007-13. 10.1177\/10781552231207839","journal-title":"J Oncol Pharm Pract"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-025-05732-z","article-title":"Prevalence and risk factors of self-reported adverse drug events in elderly co-morbid patients in northeastern China: a cross-sectional study","volume":"25","author":"Wang D","year":"2025","unstructured":"Wang D, Wang A, Meng X, Liu L. Prevalence and risk factors of self-reported adverse drug events in elderly co-morbid patients in northeastern China: a cross-sectional study. BMC Geriatr. 2025, 25:144. 10.1186\/s12877-025-05732-z","journal-title":"BMC Geriatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1714\/3431.34206","article-title":"[Polypharmacy and deprescribing in cardiology]","volume":"21","author":"Bobbio M","year":"2020","unstructured":"Bobbio M. [Polypharmacy and deprescribing in cardiology]. G Ital Cardiol (Rome). 2020, 21:801-6. 10.1714\/3431.34206","journal-title":"G Ital Cardiol (Rome)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281466","article-title":"Combinations of medicines in patients with polypharmacy aged 65-100 in primary care: large variability in risks of adverse drug related and emergency hospital admissions","volume":"18","author":"Fahmi A","year":"2023","unstructured":"Fahmi A, Wong D, Walker L, et al.. Combinations of medicines in patients with polypharmacy aged 65-100 in primary care: large variability in risks of adverse drug related and emergency hospital admissions. PLoS One. 2023, 18:e0281466. 10.1371\/journal.pone.0281466","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2024.05.202769","article-title":"[Current challenges for therapy of comorbid patients: a new look at celecoxib. A review]","volume":"96","author":"Zyryanov SK","year":"2024","unstructured":"Zyryanov SK, Baybulatova EA. [Current challenges for therapy of comorbid patients: a new look at celecoxib. A review]. Ter Arkh. 2024, 96:531-42. 10.26442\/00403660.2024.05.202769","journal-title":"Ter Arkh"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.12968\/bjcn.2021.26.6.290","article-title":"Pharmacology, polypharmacy and the older adult: a review","volume":"26","author":"Robinson P","year":"2021","unstructured":"Robinson P. Pharmacology, polypharmacy and the older adult: a review. Br J Community Nurs. 2021, 26:290-5. 10.12968\/bjcn.2021.26.6.290","journal-title":"Br J Community Nurs"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae116","article-title":"Stakeholder perceptions of and attitudes towards problematic polypharmacy and prescribing cascades: a qualitative study","volume":"53","author":"Jennings AA","year":"2024","unstructured":"Jennings AA, Doherty AS, Clyne B, et al.. Stakeholder perceptions of and attitudes towards problematic polypharmacy and prescribing cascades: a qualitative study. Age Ageing. 2024, 53:afae116. 10.1093\/ageing\/afae116","journal-title":"Age Ageing"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-025-00926-y","article-title":"Drug-drug interaction among elderly patients in Africa: a systematic review and meta-analysis","volume":"26","author":"Alemayehu TT","year":"2025","unstructured":"Alemayehu TT, Geremew GW, Tegegne AA, et al.. Drug-drug interaction among elderly patients in Africa: a systematic review and meta-analysis. BMC Pharmacol Toxicol. 2025, 26:92. 10.1186\/s40360-025-00926-y","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2019-002126","article-title":"Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity","volume":"28","author":"Otero MJ","year":"2021","unstructured":"Otero MJ, Toscano Guzm\u00e1n MD, Galv\u00e1n-Banqueri M, Martinez-Sotelo J, Santos-Rubio MD. Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity. Eur J Hosp Pharm. 2021, 28:e41-6. 10.1136\/ejhpharm-2019-002126","journal-title":"Eur J Hosp Pharm"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-017-0473-z","article-title":"Factors associated with adverse drug reactions in older inpatients in teaching hospital","volume":"39","author":"de Figueiredo TP","year":"2017","unstructured":"de Figueiredo TP, de Souza Groia RC, Barroso SC, do Nascimento MM, Reis AM. Factors associated with adverse drug reactions in older inpatients in teaching hospital. Int J Clin Pharm. 2017, 39:679-85. 10.1007\/s11096-017-0473-z","journal-title":"Int J Clin Pharm"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123529","article-title":"Polypharmacy management in chronic conditions: a systematic literature review of Italian interventions","volume":"13","author":"Perrella L","year":"2024","unstructured":"Perrella L, Mucherino S, Casula M, Illario M, Orlando V, Menditto E. Polypharmacy management in chronic conditions: a systematic literature review of Italian interventions. J Clin Med. 2024, 13:3529. 10.3390\/jcm13123529","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.13017","article-title":"Clozapine for the treatment of aggressiveness and agitation in advanced dementia","volume":"23","author":"Michael AE","year":"2023","unstructured":"Michael AE, Michael N, Erfurth A, Kujovic M. Clozapine for the treatment of aggressiveness and agitation in advanced dementia. Psychogeriatrics. 2023, 23:963-72. 10.1111\/psyg.13017","journal-title":"Psychogeriatrics"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmaa116","article-title":"An estimation of patients at potential risk for drug-induced sexual dysfunction using pharmacy dispensing data","volume":"38","author":"Gordijn R","year":"2021","unstructured":"Gordijn R, Nicolai MP, Elzevier HW, Guchelaar HJ, Teichert M. An estimation of patients at potential risk for drug-induced sexual dysfunction using pharmacy dispensing data. Fam Pract. 2021, 38:292-8. 10.1093\/fampra\/cmaa116","journal-title":"Fam Pract"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2021.07.005","article-title":"Over-the-counter remedies in older adults: patterns of use, potential pitfalls, and proposed solutions","volume":"38","author":"Safari D","year":"2022","unstructured":"Safari D, DeMarco EC, Scanlon L, Grossberg GT. Over-the-counter remedies in older adults: patterns of use, potential pitfalls, and proposed solutions. Clin Geriatr Med. 2022, 38:99-118. 10.1016\/j.cger.2021.07.005","journal-title":"Clin Geriatr Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/20451253241232563","article-title":"Drug safety in older patients with alcohol use disorder: a retrospective cohort study","volume":"14","author":"Schr\u00f6der S","year":"2024","unstructured":"Schr\u00f6der S, Westhoff MS, Pfister T, et al.. Drug safety in older patients with alcohol use disorder: a retrospective cohort study. Ther Adv Psychopharmacol. 2024, 14:20451253241232563. 10.1177\/20451253241232563","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15956","article-title":"Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: where do we stand?","volume":"91","author":"Peruzzi E","year":"2025","unstructured":"Peruzzi E, Roncato R, De Mattia E, et al.. Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: where do we stand?. Br J Clin Pharmacol. 2025, 91:270-82. 10.1111\/bcp.15956","journal-title":"Br J Clin Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3642","article-title":"How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC","volume":"27","author":"Stolfo D","year":"2025","unstructured":"Stolfo D, Iacoviello M, Chioncel O, et al.. How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2025, 27:747-59. 10.1002\/ejhf.3642","journal-title":"Eur J Heart Fail"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-022-00979-2","article-title":"Medication complexity among older adults with HF: how can we assess better?","volume":"39","author":"Kwak MJ","year":"2022","unstructured":"Kwak MJ, Cheng M, Goyal P, et al.. Medication complexity among older adults with HF: how can we assess better?. Drugs Aging. 2022, 39:851-61. 10.1007\/s40266-022-00979-2","journal-title":"Drugs Aging"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1055\/a-1120-0779","article-title":"[How to manage polypharmacia?]","volume":"146","author":"Burkhardt H","year":"2021","unstructured":"Burkhardt H. [How to manage polypharmacia?]. Dtsch Med Wochenschr. 2021, 146:15-22. 10.1055\/a-1120-0779","journal-title":"Dtsch Med Wochenschr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2023.01.008","article-title":"Oral implications of polypharmacy in older adults","volume":"39","author":"Soto AP","year":"2023","unstructured":"Soto AP, Meyer SL. Oral implications of polypharmacy in older adults. Clin Geriatr Med. 2023, 39:273-93. 10.1016\/j.cger.2023.01.008","journal-title":"Clin Geriatr Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvac005","article-title":"Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy","volume":"8","author":"Tamargo J","year":"2022","unstructured":"Tamargo J, Kjeldsen KP, Delp\u00f3n E, et al.. Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022, 8:406-19. 10.1093\/ehjcvp\/pvac005","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2196\/40456","article-title":"Automatic detection of adverse drug events in geriatric care: study proposal","volume":"11","author":"Gaspar F","year":"2022","unstructured":"Gaspar F, Lutters M, Beeler PE, et al.. Automatic detection of adverse drug events in geriatric care: study proposal. JMIR Res Protoc. 2022, 11:e40456. 10.2196\/40456","journal-title":"JMIR Res Protoc"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15621","article-title":"Risk factors for and preventability of drug-related hospital revisits in older patients: a post-hoc analysis of a randomized clinical trial","volume":"89","author":"Kempen TG","year":"2023","unstructured":"Kempen TG, Hedman AN, Hadziosmanovic N, et al.. Risk factors for and preventability of drug-related hospital revisits in older patients: a post-hoc analysis of a randomized clinical trial. Br J Clin Pharmacol. 2023, 89:1575-87. 10.1111\/bcp.15621","journal-title":"Br J Clin Pharmacol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-021-03213-x","article-title":"Medication-related adverse events in health care-what have we learned? A narrative overview of the current knowledge","volume":"78","author":"Laatikainen O","year":"2022","unstructured":"Laatikainen O, Sneck S, Turpeinen M. Medication-related adverse events in health care-what have we learned? A narrative overview of the current knowledge. Eur J Clin Pharmacol. 2022, 78:159-70. 10.1007\/s00228-021-03213-x","journal-title":"Eur J Clin Pharmacol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa188","article-title":"In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs\u2014a systematic review and meta-analysis","volume":"49","author":"Jennings EL","year":"2020","unstructured":"Jennings EL, Murphy KD, Gallagher P, O'Mahony D. In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs\u2014a systematic review and meta-analysis. Age Ageing. 2020, 49:948-58. 10.1093\/ageing\/afaa188","journal-title":"Age Ageing"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5800","article-title":"Medication-related problems in geriatric psychiatry\u2014a retrospective cohort study","volume":"37","author":"Heck J","year":"2022","unstructured":"Heck J, Ihlefeld C, Krause O, et al.. Medication-related problems in geriatric psychiatry\u2014a retrospective cohort study. Int J Geriatr Psychiatry. 2022, 37:0. 10.1002\/gps.5800","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2025.06.026","article-title":"Adverse drug reaction-related hospital admissions in older adults with diabetes: incidence and implicated drug classes","volume":"31","author":"Vonna A","year":"2025","unstructured":"Vonna A, Salahudeen MS, Peterson GM. Adverse drug reaction-related hospital admissions in older adults with diabetes: incidence and implicated drug classes. Endocr Pract. 2025, 31:1441-8. 10.1016\/j.eprac.2025.06.026","journal-title":"Endocr Pract"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad003","article-title":"Dual attention and patient similarity network for drug recommendation","volume":"39","author":"Wu J","year":"2023","unstructured":"Wu J, Dong Y, Gao Z, Gong T, Li C. Dual attention and patient similarity network for drug recommendation. Bioinformatics. 2023, 39:btad003. 10.1093\/bioinformatics\/btad003","journal-title":"Bioinformatics"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192315902","article-title":"Comprehensive multimorbidity patterns in older patients are associated with quality indicators of medication-MoPIM cohort study","volume":"19","author":"Lleal M","year":"2022","unstructured":"Lleal M, Bar\u00e9 M, Ortonobes S, et al.. Comprehensive multimorbidity patterns in older patients are associated with quality indicators of medication-MoPIM cohort study. Int J Environ Res Public Health. 2022, 19:15902. 10.3390\/ijerph192315902","journal-title":"Int J Environ Res Public Health"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afab196","article-title":"Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial","volume":"51","author":"Zerah L","year":"2022","unstructured":"Zerah L, Henrard S, Thevelin S, et al.. Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial. Age Ageing. 2022, 51:10.1093\/ageing\/afab196","journal-title":"Age Ageing"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01181-3","article-title":"Incident adverse drug reactions and their effect on the length of hospital stay in older inpatients","volume":"43","author":"Sandoval T","year":"2021","unstructured":"Sandoval T, Mart\u00ednez M, Miranda F, Jir\u00f3n M. Incident adverse drug reactions and their effect on the length of hospital stay in older inpatients. Int J Clin Pharm. 2021, 43:839-46. 10.1007\/s11096-020-01181-3","journal-title":"Int J Clin Pharm"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-024-04059-4","article-title":"Citral and triclosan synergistically silence quorum sensing and potentiate antivirulence response in Pseudomonas aeruginosa","volume":"206","author":"Chadha J","year":"2024","unstructured":"Chadha J, Ahuja P, Mudgil U, Khullar L, Harjai K. Citral and triclosan synergistically silence quorum sensing and potentiate antivirulence response in Pseudomonas aeruginosa. Arch Microbiol. 2024, 206:324. 10.1007\/s00203-024-04059-4","journal-title":"Arch Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424645-adverse-drug-reactions-and-drug-interactions-in-multimorbid-patients-a-review-of-current-evidence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:26:55Z","timestamp":1763987215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424645-adverse-drug-reactions-and-drug-interactions-in-multimorbid-patients-a-review-of-current-evidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":56,"URL":"https:\/\/doi.org\/10.7759\/cureus.97640","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}